Eagle Asset Management Inc. purchased a new stake in shares of MetLife, Inc. (NYSE:MET - Free Report) during the third quarter, according to its most recent filing with the Securities & Exchange Commission. The firm purchased 106,678 shares of the financial services provider's stock, valued at approximately $8,643,000.
Other large investors have also recently made changes to their positions in the company. SVB Wealth LLC boosted its stake in shares of MetLife by 2.5% during the first quarter. SVB Wealth LLC now owns 10,115 shares of the financial services provider's stock valued at $750,000 after purchasing an additional 250 shares during the period. Waverly Advisors LLC increased its position in shares of MetLife by 1.7% in the first quarter. Waverly Advisors LLC now owns 15,935 shares of the financial services provider's stock valued at $1,181,000 after acquiring an additional 266 shares during the period. Jacobs Levy Equity Management Inc. raised its stake in shares of MetLife by 5.0% during the first quarter. Jacobs Levy Equity Management Inc. now owns 138,113 shares of the financial services provider's stock valued at $10,236,000 after acquiring an additional 6,577 shares during the last quarter. Industrial Alliance Investment Management Inc. grew its stake in shares of MetLife by 3.3% in the first quarter. Industrial Alliance Investment Management Inc. now owns 7,890 shares of the financial services provider's stock worth $585,000 after purchasing an additional 250 shares during the last quarter. Finally, Sweeney & Michel LLC purchased a new stake in MetLife in the 1st quarter worth approximately $469,000. 89.81% of the stock is owned by hedge funds and other institutional investors.
MetLife Price Performance
MET stock traded up $0.75 during mid-day trading on Monday, hitting $87.34. The company had a trading volume of 4,018,446 shares, compared to its average volume of 3,310,028. The company has a quick ratio of 0.16, a current ratio of 0.16 and a debt-to-equity ratio of 0.51. MetLife, Inc. has a 12-month low of $62.81 and a 12-month high of $87.64. The company has a 50-day moving average price of $82.48 and a 200 day moving average price of $76.08. The company has a market capitalization of $60.48 billion, a price-to-earnings ratio of 17.46, a P/E/G ratio of 0.79 and a beta of 1.05.
MetLife Announces Dividend
The business also recently disclosed a quarterly dividend, which will be paid on Monday, December 16th. Shareholders of record on Tuesday, November 5th will be paid a dividend of $0.545 per share. The ex-dividend date is Tuesday, November 5th. This represents a $2.18 annualized dividend and a yield of 2.50%. MetLife's payout ratio is currently 43.95%.
Analyst Ratings Changes
Several research firms recently weighed in on MET. StockNews.com upgraded shares of MetLife from a "hold" rating to a "buy" rating in a report on Tuesday, November 12th. Bank of America reduced their price target on shares of MetLife from $99.00 to $96.00 and set a "buy" rating on the stock in a research report on Thursday, August 1st. Jefferies Financial Group lifted their price objective on MetLife from $89.00 to $95.00 and gave the company a "buy" rating in a research report on Friday, September 27th. Morgan Stanley decreased their target price on MetLife from $86.00 to $85.00 and set an "overweight" rating for the company in a research report on Monday, August 19th. Finally, Wells Fargo & Company increased their price objective on MetLife from $92.00 to $93.00 and gave the stock an "overweight" rating in a report on Tuesday, November 5th. Fourteen equities research analysts have rated the stock with a buy rating, Based on data from MarketBeat.com, the stock presently has an average rating of "Buy" and an average price target of $88.46.
Read Our Latest Stock Analysis on MetLife
MetLife Profile
(
Free Report)
MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.
Further Reading
Before you consider MetLife, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and MetLife wasn't on the list.
While MetLife currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Growth stocks offer a lot of bang for your buck, and we've got the next upcoming superstars to strongly consider for your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.